Peptide Therapy · SS-31 · Serving South Metro Denver

Rather than primarily targeting hormone or growth-factor pathways, SS-31 is designed to act directly within the mitochondria. This makes its potential effects on cellular energy and mitochondrial function a major focus of research.

Because mitochondria produce most of the energy used by cells, SS-31 is being studied for its potential to support efficient cellular energy production. This should not be interpreted as a guaranteed increase in day-to-day energy.

Research has explored mitochondrial-targeted therapies for their potential effects on muscle function, exercise capacity, cellular resilience, and recovery. Clinical evidence for SS-31 for general performance or recovery purposes remains limited.

There is no established timeline for wellness or performance-related use. Individual response may vary depending on health status, treatment goals, protocol, and other factors.

We kindly ask for at least 24 hours’ notice to cancel or reschedule your appointment. Cancellations within 24 hours will incur a 50% fee. If we arrive and are unable to reach you or access the appointment location after a brief grace period, the visit will be considered a no-show and may be charged up to the full service amount. Same-day bookings require a minimum of 4 hours’ notice for any changes. As each appointment is reserved exclusively for you — including provider time and travel — we appreciate your understanding.

Pregnancy or breastfeeding, certain significant medical conditions, medication interactions, allergies, or other individual risk factors may affect candidacy. A medical evaluation is important before considering treatment.

I’d be careful with the wording on this FAQ because elamipretide’s regulatory status has been evolving. Before publishing the page, I’d verify its current FDA status rather than using a blanket “not FDA-approved” statement, especially given recent regulatory activity surrounding elamipretide.

There is no established treatment timeline, and individual response can vary based on baseline skin tone, genetics, dose, and other factors. Changes in pigmentation may develop gradually rather than immediately.

Yes. Increased pigmentation does not eliminate the risk of UV-related skin damage or skin cancer. Broad-spectrum sunscreen and appropriate sun-protective measures remain important.

Melanotan II can increase pigmentation, but intentional UV exposure carries established risks and should not be considered “safe” because Melanotan II is being used. We would avoid positioning tanning beds or additional UV exposure as part of the treatment protocol.

It can increase pigmentation of existing freckles, moles, and other pigmented areas. Any new, rapidly changing, irregular, bleeding, itching, or otherwise concerning lesion should be evaluated by a qualified dermatology provider.

We kindly ask for at least 24 hours’ notice to cancel or reschedule your appointment. Cancellations within 24 hours will incur a 50% fee. If we arrive and are unable to reach you or access the appointment location after a brief grace period, the visit will be considered a no-show and may be charged up to the full service amount. Same-day bookings require a minimum of 4 hours’ notice for any changes. As each appointment is reserved exclusively for you — including provider time and travel — we appreciate your understanding.

Candidacy requires individualized medical evaluation. A history of melanoma or other skin cancers, atypical/dysplastic nevi, concerning pigmented lesions, pregnancy or breastfeeding, or certain medical conditions may make treatment inappropriate or warrant additional evaluation.

Reported effects can include nausea, flushing, decreased appetite, headache, fatigue, increased pigmentation of freckles or moles, and changes in libido or spontaneous erections. Because Melanotan II is investigational, its complete long-term safety profile has not been established.